Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
C4X Discovery Holdings PLC (GB:C4XD)
LSE:C4XD
Holding GB:C4XD?
Track your performance easily
C4XD Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range7.00p - 22.00p
Previous Close12p
Volume0.00
Average Volume (3M)1.09M
Market Cap
£30.27M
Enterprise Value26.47M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)3.1
Beta0.65
Next Earnings
Dec 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding252,227,097
10 Day Avg. Volume215,359
30 Day Avg. Volume1,088,545
Standard Deviation0.15
R-Squared0.01
Alpha-0.00702
Financial Highlights & Ratios
Price to Book (P/B)1126.67
Price to Sales (P/S)250743.42
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
C4X Discovery Holdings News
PremiumCompany Announcements
C4X Discovery Moves to Private Trading
PremiumCompany Announcements
C4X Discovery Shareholding Shift Notified
Options Prices
Currently, No data available
---
Ownership Overview
1.01% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
98.99% Public Companies and
Individual Investors
C4XD FAQ
What was C4X Discovery Holdings PLC’s price range in the past 12 months?
C4X Discovery Holdings PLC lowest share price was 7.00p and its highest was 22.00p in the past 12 months.
What is C4X Discovery Holdings PLC’s market cap?
Currently, no data Available
When is C4X Discovery Holdings PLC’s upcoming earnings report date?
C4X Discovery Holdings PLC’s upcoming earnings report date is Dec 12, 2024 which is in 19 days.
How were C4X Discovery Holdings PLC’s earnings last quarter?
C4X Discovery Holdings PLC released its earnings results on Mar 27, 2024. The company reported 0.071p earnings per share for the quarter, beating the consensus estimate of N/A by 0.071p.
Is C4X Discovery Holdings PLC overvalued?
According to Wall Street analysts C4X Discovery Holdings PLC’s price is currently Overvalued.
Does C4X Discovery Holdings PLC pay dividends?
C4X Discovery Holdings PLC does not currently pay dividends.
What is C4X Discovery Holdings PLC’s EPS estimate?
C4X Discovery Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does C4X Discovery Holdings PLC have?
C4X Discovery Holdings PLC has 252,227,110 shares outstanding.
What happened to C4X Discovery Holdings PLC’s price movement after its last earnings report?
C4X Discovery Holdings PLC reported an EPS of 0.071p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -24.242%.
Which hedge fund is a major shareholder of C4X Discovery Holdings PLC?
Currently, no hedge funds are holding shares in GB:C4XD
---
C4X Discovery Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth £50.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.08%
12-Months-Change
Fundamentals
Return on Equity
55.38%
Trailing 12-Months
Asset Growth
66.74%
Trailing 12-Months
Company Description
C4X Discovery Holdings PLC
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.
---
Technical Analysis
Best Analysts Covering C4XD
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 12 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---